| Laura Kaye Hamdani, MA, CCC-SLP | |
|
2701 Chestnut Station Ct, Louisville, KY 40299-6395 | |
| (800) 335-1060 | |
| Not Available |
| Full Name | Laura Kaye Hamdani |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 2701 Chestnut Station Ct, Louisville, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003408378 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 22004732A (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Laura Kaye Hamdani, MA, CCC-SLP 508 Loveland Pass Ct, Osceola, IN 46561-8425 Ph: (574) 370-4326 | Laura Kaye Hamdani, MA, CCC-SLP 2701 Chestnut Station Ct, Louisville, KY 40299-6395 Ph: (800) 335-1060 |
News Archive
I'll submit legislation to repeal ObamaCare, and on day one issue an executive order ending related regulatory obligations on the states. I'll work with Congress to replace ObamaCare with competitive insurance choices to improve quality and limit the costs of health care, while protecting those with uninsurable health conditions.
Researchers from the University of Alicante (UA) taking part in the European VACSATC project have studied mothers' and fathers' opinions on vaccinating their children in five countries. The results of the survey show that Spanish mothers are more resistant than those in other countries to the idea of paying for vaccines, while 20.9% expressed some concern about the safety of vaccines.
Developing a universal influenza vaccine - a vaccine that can provide durable protection for all age groups against multiple influenza strains, including those that might cause a pandemic - is a priority for the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
Should the UK lower the age for prostate cancer detection in line with the USA?
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has initiated a Phase 2 clinical trial in Canada with its novel defensin-mimetic antibiotic, PMX-30063.
› Verified 8 days ago
Samantha Hii, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2701 Chestnut Station Ct, Louisville, KY 40299 Phone: 800-335-1060 | |
Mrs. Lauren Elizabeth Ewing, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2701 Chestnut Station Ct, Paragon Rehabilitation, Louisville, KY 40299 Phone: 800-335-1060 | |
Amy L Scott, M.S.,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2701 Chestnut Station Ct, Louisville, KY 40299 Phone: 800-335-1060 | |
Stephanie Jill Dyer, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3920 Dutchmans Ln, Louisville, KY 40207 Phone: 502-259-6608 | |
Kymberly Jean Pennington, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2701 Chestnut Station Ct, Louisville, KY 40299 Phone: 800-335-1060 | |
Joyce M Wooldridge, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1410 Long Run Rd, Louisville, KY 40245 Phone: 502-244-8011 |